Search Results - "Lestingi, Jean F.P"

Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial by Lestingi, Jean F.P., Guglielmetti, Giuliano B., Trinh, Quoc-Dien, Coelho, Rafael F., Pontes, Jose, Bastos, Diogo A., Cordeiro, Mauricio D., Sarkis, Alvaro S., Faraj, Sheila F., Mitre, Anuar I., Srougi, Miguel, Nahas, William C.

“…The role of extended pelvic lymph node dissection (EPLND) in the surgical management of prostate cancer (PCa) patients remains controversial, mainly because of…”
Get full text

PD43-06 EXTENDED VS LIMITED PELVIC LYMPHADENECTOMY DURING RADICAL PROSTATECTOMY FOR INTERMEDIATE- AND HIGH-RISK PROSTATE CANCER: A PROSPECTIVE RANDOMIZED TRIAL by Lestingi, Jean F.P, Pontes Jr, Jose, Borges, Leonardo L, Ravanini, Juliana, Guglielmetti, Giuliano B, Cordeiro, Mauricio D, Coelho, Rafael F, Nahas, William C

Get full text

Reply to Alberto Briganti, Giorgio Gandaglia, Markus Graefen, Steven Joniau, R. Jeffrey Karnes, and Francesco Montorsi’s Letter to the Editor re: Jean F.P. Lestingi, Giuliano B. Guglielmetti, Quoc-Dien Trinh, et al. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial. Eur Urol 2021;79:595–604. Time for a Change? Clinically Meaningful Reasons Why We Will Contin by Lestingi, Jean F.P., Trinh, Quoc-Dien, Coelho, Rafael F., Pontes, Jose, Bastos, Diogo A., Nahas, William C.

Get full text

Reply to: Axel Heidenreich. Still Unanswered: The Role of Extended Pelvic Lymphadenectomy in Improving Oncological Outcomes in Prostate Cancer. Eur Urol 2021;79:605–6 by Lestingi, Jean F.P., Guglielmetti, Giuliano B., Trinh, Quoc-Dien, Coelho, Rafael F., Pontes, Jose, Bastos, Diogo A., Cordeiro, Mauricio D., Sarkis, Alvaro S., Faraj, Sheila F., Mitre, Anuar I., Srougi, Miguel, Nahas, William C.

Get full text